BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 75 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,433,507 | +32.6% | 1,756,145 | +31.9% | 0.03% | +37.5% |
| Q2 2023 | $9,373,676 | -16.1% | 1,331,488 | -0.7% | 0.02% | -25.0% |
| Q1 2023 | $11,178,252 | +89.5% | 1,340,318 | +160.8% | 0.03% | +68.4% |
| Q4 2022 | $5,899,652 | -54.6% | 513,907 | -50.2% | 0.02% | -56.8% |
| Q3 2022 | $12,993,000 | +406.4% | 1,031,159 | +325.1% | 0.04% | +450.0% |
| Q2 2022 | $2,566,000 | -20.8% | 242,541 | +21.8% | 0.01% | -20.0% |
| Q1 2022 | $3,238,000 | -80.9% | 199,124 | -83.7% | 0.01% | -72.2% |
| Q4 2021 | $16,941,000 | -48.0% | 1,223,189 | -46.1% | 0.04% | -50.7% |
| Q3 2021 | $32,586,000 | +11.4% | 2,267,645 | +22.5% | 0.07% | +10.6% |
| Q2 2021 | $29,256,000 | +4825.3% | 1,850,485 | +3070.3% | 0.07% | +3200.0% |
| Q1 2021 | $594,000 | -92.6% | 58,369 | -94.6% | 0.00% | -91.3% |
| Q4 2020 | $7,997,000 | +18.5% | 1,073,416 | -45.4% | 0.02% | -4.2% |
| Q3 2020 | $6,751,000 | -50.5% | 1,965,439 | -31.4% | 0.02% | -64.7% |
| Q2 2020 | $13,644,000 | +502.9% | 2,863,381 | +153.1% | 0.07% | +277.8% |
| Q1 2020 | $2,263,000 | -54.0% | 1,131,521 | -20.6% | 0.02% | +20.0% |
| Q4 2019 | $4,918,000 | +126.3% | 1,425,455 | +88.0% | 0.02% | +114.3% |
| Q3 2019 | $2,173,000 | +1.3% | 758,399 | +34.0% | 0.01% | 0.0% |
| Q2 2019 | $2,146,000 | -3.6% | 566,169 | +106.9% | 0.01% | 0.0% |
| Q1 2019 | $2,227,000 | +1435.9% | 273,608 | +1420.0% | 0.01% | +600.0% |
| Q4 2018 | $145,000 | -87.2% | 18,000 | -87.9% | 0.00% | -66.7% |
| Q3 2018 | $1,134,000 | +39.5% | 148,649 | +4.8% | 0.00% | +50.0% |
| Q2 2018 | $813,000 | +220.1% | 141,821 | +166.6% | 0.00% | +100.0% |
| Q1 2018 | $254,000 | -82.3% | 53,200 | -81.7% | 0.00% | -80.0% |
| Q4 2017 | $1,431,000 | +161.1% | 291,428 | +178.8% | 0.01% | +150.0% |
| Q3 2017 | $548,000 | -71.1% | 104,547 | -69.3% | 0.00% | -71.4% |
| Q2 2017 | $1,896,000 | -50.7% | 341,013 | -25.5% | 0.01% | -46.2% |
| Q1 2017 | $3,844,000 | +1407.5% | 457,647 | +1035.4% | 0.01% | +1200.0% |
| Q4 2016 | $255,000 | -92.2% | 40,308 | -84.4% | 0.00% | -93.3% |
| Q2 2014 | $3,288,000 | +1070.1% | 257,889 | +596.2% | 0.02% | +650.0% |
| Q4 2013 | $281,000 | -69.1% | 37,043 | -70.3% | 0.00% | -66.7% |
| Q3 2013 | $908,000 | – | 124,656 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |